EUVIMED · CrossrefJournal
Clinical Pharmacology in Drug Development
ISSN 2160-763X · Wiley
Latest articles
Comparability of Pharmacokinetics, Safety, and Tolerability of Canakinumab Administration With One Injection (200 mg) of Pre‐Filled Syringe or Auto‐Injector Versus Two Injections (150 and 50 mg) of Pre‐Filled Syringe in Healthy Subjects
Drug–Drug Interaction Assessment of WXFL10203614 With Rifampicin, Itraconazole and Metformin: A Three‐Cohort Phase I Study
A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants
Pharmacogenomics as a Design Input in Early‐Phase Drug Development
Issue Information
Comparison of ABBV‐552 Safety and Pharmacokinetics in Healthy Asian and Western Adults
Bioequivalence of Two Firsekibart Subcutaneous Formulations: A Randomized, Double‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Chinese Participants
Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions
Beyond the “Undruggable”: What Pancreatic Cancer Teaches Us About the Next Evolution of Clinical Pharmacology
Pharmacokinetics and Bioequivalence Study of Levodopa and Benserazide Tablets in Healthy Chinese Subjects Under Fasting and High‐Fat Meal Conditions
Issue Information
Comparative bioavailability of a novel fixed‐dose combination of ticagrelor and acetylsalicylic acid
Phase 1 Study of Paltusotine, a Novel Oral Once‑Daily, Nonpeptide Selective Somatostatin Receptor 2 Agonist, in Healthy Japanese Adults
Population Pharmacokinetic‐Based Meropenem Dosing in Critically and Non‐Critically Ill Patients with Mixed Gram‐Negative Bacterial Infections
Scientific Fraud: How Do We Ensure Sound Medical Literature?
Effect of High‐Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric‐Coated Capsules in Healthy Chinese Subjects
Pacritinib Impact on QT Interval: Results of a Thorough QT Study and Post Hoc Analysis of Prospective Clinical Trial Data
Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open‐Label, Four‐Period Crossover Study Under Fasting and Fed Conditions
Comparative Pharmacokinetics of Two Extended‐Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment
Issue Information
A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate‐Release Tablet in Healthy Adults
Bioequivalence of a Fixed‐Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open‐Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions
A Phase 1, Open‐Label, Single‐Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor
Ethnic Bridging of Votoplam, a HTT Gene Splicing Modifier, Using Pharmacokinetic Comparison Between Caucasian and Japanese Subjects
Comparative Pharmacokinetics and Bioequivalence Assessment of Metformin/Pioglitazone Tablet in Fasting and Fed Conditions: A Randomized Study in Healthy Chinese Subjects
The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
Issue Information
Are We Overstudying Biosimilars? Re‐Centering Clinical Pharmacology in the Demonstration of Similarity
Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions
A Randomized, Double‐Blinded, Placebo‐Controlled QTc Study to Evaluate BIA 28–6156 Effect on Cardiac Repolarization in Healthy Volunteers
EUVIMED